- Home
- CXAI vs GOVX Comparison
CXAI vs GOVX Comparison
Compare CXAI & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- GOVX
- Stock Information
- Founded
- CXAI N/A
- GOVX 2001
- Country
- CXAI United States
- GOVX United States
- Employees
- CXAI N/A
- GOVX N/A
- Industry
- CXAI EDP Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- GOVX Health Care
- Exchange
- CXAI Nasdaq
- GOVX Nasdaq
- Market Cap
- CXAI 26.7M
- GOVX 23.8M
- IPO Year
- CXAI N/A
- GOVX N/A
- Fundamental
- Price
- CXAI $1.79
- GOVX $2.22
- Analyst Decision
- CXAI
- GOVX Strong Buy
- Analyst Count
- CXAI 0
- GOVX 5
- Target Price
- CXAI N/A
- GOVX $14.20
- AVG Volume (30 Days)
- CXAI 1.4M
- GOVX 759.4K
- Earning Date
- CXAI 11-12-2024
- GOVX 02-27-2025
- Dividend Yield
- CXAI N/A
- GOVX N/A
- EPS Growth
- CXAI N/A
- GOVX N/A
- EPS
- CXAI N/A
- GOVX N/A
- Revenue
- CXAI $7,200,000.00
- GOVX $3,090,161.00
- Revenue This Year
- CXAI $3.86
- GOVX N/A
- Revenue Next Year
- CXAI $100.00
- GOVX $150.51
- P/E Ratio
- CXAI N/A
- GOVX N/A
- Revenue Growth
- CXAI N/A
- GOVX N/A
- 52 Week Low
- CXAI $1.03
- GOVX $1.09
- 52 Week High
- CXAI $7.07
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- CXAI 48.67
- GOVX 44.57
- Support Level
- CXAI $1.64
- GOVX $2.04
- Resistance Level
- CXAI $2.54
- GOVX $2.32
- Average True Range (ATR)
- CXAI 0.23
- GOVX 0.18
- MACD
- CXAI -0.03
- GOVX -0.02
- Stochastic Oscillator
- CXAI 16.74
- GOVX 25.35
About CXAI CXApp Inc.
CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.